Cleared Traditional

K171957 - MaxZero Extension Sets with Needless Co...

K171957 is an FDA 510(k) clearance for MaxZero Extension Sets with Needless Co..., manufactured by Carefusion 303, Inc.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 20-day FDA review.

K171957 · Carefusion 303, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2017
Decision
20d
Days
Class 2
Risk

K171957 is an FDA 510(k) clearance for the MaxZero Extension Sets with Needless Connector. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Carefusion 303, Inc. (San Diego, US). The FDA issued a Cleared decision on July 19, 2017 after a review of 20 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Carefusion 303, Inc. devices

FDA 510(k) Submission Details - K171957

510(k) Number K171957 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 29, 2017
Decision Date July 19, 2017
Days to Decision 20 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
109d faster than avg
Panel avg: 129d · This submission: 20d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 533
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K171957.
IV Administration Sets
K170595 · B.Braun Medical, Inc. · Nov 2017
IV Fat Emulsion Administration Sets
K172544 · Baxter Healthcare Corporation · Sep 2017
Medline Blood Collection Set
K170002 · Medline Industries, Inc. · Sep 2017
Solution Set with 1.2 Micron Air Eliminating Filter
K161808 · Baxter Healthcare Corporation · Jun 2017
Q2 Low Pressure Power Injection Extension Set
K162804 · Quest Medical, Inc. · Mar 2017
Hospira Extension Set, Hospira Primary Set
K161036 · Hospira, Inc. · Jan 2017